Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for targeted cancer therapies. Its structure supports modification for enhanced binding affinity to specific enzyme targets. Commonly employed in research settings to design compounds with potential antitumor and anti-inflammatory activity. Also utilized in the preparation of novel heterocyclic compounds for drug discovery programs.